Adaptive Biotechnologies's total assets for Q1 2025 were $510.85M, a decrease of -5.29% from the previous quarter. ADPT total liabilities were $320.63M for the fiscal quarter, a -4.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.